Tekla Healthcare Investors
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
DIMARTINO ROSE director
 Common Stock 1,000 $18.88 $18,880
Purchase
GOETZ KATHLEEN director
 Common Stock 525 $16.42 $8,623
Purchase
REIT TODD director
 Common Stock 1,000 $16.93 $16,929
Purchase
MAHER BILL director
 Common Stock 1,000 $16.58 $16,580
Purchase
GOODSON ALAN R officer: Vice President
 Common stock 170 $16.13 $2,742
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 9,500 $15.63 $148,514
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 9,500 $15.88 $150,832
Purchase
GOETZ KATHLEEN director:
Shares of Beneficial Interest 73 $20.42 $1,490
Purchase
GOETZ KATHLEEN director
 Shares of Beneficial Interest 481 $21.52 $10,349
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 5,200 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 5,050 N/A N/A
Purchase
BAILEY JEFFREY ALLEN director
 Shares of Beneficial Interest 490 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 5,000 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 6,800 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 6,300 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 5,500 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 3,882 N/A N/A
Purchase
KENT THOMAS M director
 Shares of Beneficial Interest 1,100 N/A N/A
Purchase
GASPERONI TIMOTHY L other: Senior Vice President Re..
 Shares of Beneficial Interest 862 N/A N/A
Purchase
STEBBINS LUCINDA H director
 Shares of Beneficial Interest 2,000 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 5,000 N/A N/A
Purchase
POHOTSKY OLEG M director
 Shares of beneficial interest 200 N/A N/A
Purchase
REARDON WILLIAM S director
 Shares of Beneficial Interest 646 N/A N/A
Purchase
BONNEY MICHAEL W director
 Shares of Beneficial Interest 650 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of beneficial interest 8,100 N/A N/A
Purchase
STEBBINS LUCINDA H director
 Shares of beneficial interest 1,000 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of beneficial interest 3,000 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of beneficial interest 2,000 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of beneficial interest 387 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of beneficial interest 1,500 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 1,500 N/A N/A
Purchase
STEBBINS LUCINDA H director
 Shares of Beneficial Interest 1,000 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 1,000 N/A N/A
Purchase
STEBBINS LUCINDA H director
 H&Q Healthcare Investors 3,000 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 H&Q Healthcare Investors 2,700 N/A N/A
Purchase
OMSTEAD DANIEL R director, officer: President
 Shares of Beneficial Interest 800 N/A N/A
Purchase
MACK ROBERT P director
 Shares of Beneficial Interest 1,246 N/A N/A
Purchase
LEWIN LAWRENCE S director
 Shares of Beneficial Interest 1,488 N/A N/A

Showing 1 to 38 of 38 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: